N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.
Kornhuber
J
J
Riederer
P
P
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
D000317:Adrenergic alpha-Antagonists; D010880:Piperidines; D016194:Receptors, N-Methyl-D-Aspartate; C010739:ifenprodil